UNSPSC 51284003: Clomocycline

This classification denotes a tetracycline antibiotic with the molecular formula C23H25ClN2O9, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YP0241BU76, chemically known as 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-n-(hydroxymethyl)-6-methyl-1,11-dioxo-2-naphthacenecarboxamide but generally known as clomocycline, which bears US NIH Compound Identifier 5464321.

UNSPSC 51284003 Clomocycline is a Commodity code that, based on recent state and local procurement activity, is being applied to a broader class of pharmaceutical products and medical supplies rather than to clomocycline specifically. State and local governments are buying generic multi-source pharmaceuticals, over-the-counter products, naloxone, medical and first aid supplies for emergency response, and components of direct-to-manufacturer prescription programs under this code designation. The issuing bodies include state health and human services commissions, county health departments, and municipal fire departments; the Minnesota Department of Administration and Texas Health and Human Services Commission appear as repeat buyers in recent solicitations. Work being solicited ranges from bulk pharmaceutical supply agreements through authorized wholesalers to specialized emergency medical supplies for first responder use, with contracts typically structured as multi-year awards with renewal options and pricing based on competitive bidding or cost-plus administrative fees.

Recent activity appears concentrated in Texas, Florida, and Minnesota. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP (S1070000015802) on January 20, 2026, with proposals due March 26, 2026, for generic multi-source pharmaceuticals and OTC products; the contract will be effective July 1, 2026, and involves distribution through AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., LLC. Seminole County, Florida issued an IFB (IFB60459723LAS) on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually, with a response deadline of July 26, 2026, and quarterly deliveries to the Seminole County Community Health Building. The City of Tampa released an ITB (26P00145) on March 25, 2026, for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, estimated at $700,000, with a sheltered-market set-aside for certified Small Local Business Enterprises and a 5 percent SLBE bid discount. The Texas Health and Human Services Commission issued an RFI (HHS0017013) on April 3, 2026, to explore direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager relationships.